Mesoblast Director Philip R. Krause, M.D., Appointed to Strategic Advisory Role

05.06.2023 - NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) - Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, is pleased to announce that it has appointed Dr. Philip R. Krause, a member of the Board ... Seite 1

Related Keywords

Philipr Krause , ,Mesoblast Limited Nasdaq ,Drug Administration ,Office Of Vaccines Research ,Deputy Director ,Vaccines Research ,Biologics Evaluation ,Mesoblast ,